| Generic Name | Originator | Primary Therapy Description | Primary Pharmacology Description |
|---|---|---|---|
| abatacept | Bristol-Myers Squibb | Immunoglobulin, non-MAb | CD28 antagonist |
| alglucosidase alfa | Genzyme | Recombinant, other | Alpha glucosidase stimulant |
| anecortave acetate | Alcon | Ophthalmological | Angiogenesis inhibitor |
| anidulafungin | Eli Lilly | Antifungal | Cell wall synthesis inhibitor |
| conivaptan hydrochloride | Astellas | Antihypertensive, diuretic | Vasopressin 1 antagonist |
| darunavir | Johnson & Johnson | Antiviral, anti-HIV | HIV protease inhibitor |
| dasatinib | Bristol-Myers Squibb | Anticancer, other | Bcr-Abl inhibitor |
| decitabine | SuperGen | Anticancer, antimetabolite | DNA methylase inhibitor |
| ivabradine hydrochloride | Servier | Antianginal | Sodium channel antagonist |
| HPV vaccine, CSL | CSL | Recombinant vaccine | Immunostimulant |
| LC16m8 | VaxGen | Prophylactic vaccine | Immunostimulant |
| lenalidomide | Celgene | Anticancer, other | Tumour necrosis factor α antagonist |
| lubiprostone | Sucampo Pharmaceuticals | Laxative | Chloride channel-2 agonist |
| mecasermin rinfabate | Insmed | Recombinant hormone | Insulin like growth factor 1 agonist |
| mozavaptan | Otsuka | Metabolic and enzyme disorders | Vasopressin 2 antagonist |
| panitumumab | Amgen | Monoclonal antibody, human | ErbB-1 inhibitor |
| Phleum pratense grass tablet | ALK-Abello | Antiallergic, non-asthma | Unidentified pharmacological activity |
| pramlintide | Amylin | Antidiabetic | Amylin agonist |
| ranibizumab | Genentech | Monoclonal antibody, humanized | Endothelial growth factor antagonist |
| ranolazine | Hoffmann-La Roche | Antianginal | Partial fatty acid oxidation inhibitor |
| rimonabant | Sanofi-Aventis | Anorectic/Antiobesity | Cannabinoid CB1 antagonist |
| rotavirus vaccine, Merck | Merck & Co | Prophylactic vaccine | Immunostimulant |
| rotigotine | UCB | Antiparkinsonian | Dopamine D2 agonist |
| shingles vaccine, Merck | Merck & Co | Prophylactic vaccine | Immunostimulant |
| silodosin | Kissei | Urological | Alpha 1 adrenoreceptor antagonist |
| sitagliptin phosphate | Merck & Co | Antidiabetic | Dipeptidyl peptidase IV inhibitor |
| sitaxsentan sodium | Encysive Pharmaceuticals | Antihypertensive, other | Endothelin A receptor antagonist |
| sunitinib malate | Pfizer | Anticancer, other | Endothelial growth factor receptor kinase inhibitor |
| telbivudine | Novartis | Antiviral, other | DNA directed DNA polymerase inhibitor |
| udenafil | Dong-A | Male sexual dysfunction | Phosphodiesterase V inhibitor |
| vareniclinie tartrate | Pfizer | Dependence treatment | Neuronal nicotinic receptor antagonist |
| New active substances first launched during 2006 - © Informa UK Ltd | |||